Source: Annual Congress 2013 –Genetics and mechanisms of, and tests for, allergy
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
A. Gawlewicz-Mroczka, J. Kumik, M. Kaszuba, A. Gielicz, M. Sanak, E. Nizankowska-Mogilnicka, L. Mastalerz, A. Szczeklik (Krakow, Poland). Measurements of prostaglandins E2 and D2 and their metabolites in exhaled breath condensate following bronchial provocation with aspirin in asthmatics. Eur Respir J 2013; 42: Suppl. 57, 895

Member's Comments

No comment yet.

Related content which might interest you: Prostaglandin E2 in the expired breath condensate of patients with asthma Source: Eur Respir J 2003; 22: 743-747 Year: 2003 The effect of smoking on the levels of cysteinyl leukotriene in exhaled breath condensate in asthmatics Source: Annual Congress 2012 - Asthma: assessment and treatment Year: 2012 Atopic asthma: leukotriene metabolites in breath condensate and in urine Source: Eur Respir J 2002; 20: Suppl. 38, 412s Year: 2002 Thromboxane B2 and prostaglandin E2 concentrations in exhaled breath condensate in healthy volunteers and patients with bronchial asthma Source: Eur Respir J 2002; 20: Suppl. 38, 509s Year: 2002 Cysteinyl leukotrienes in urine and exhaled breath condensate in asthmatics and COPD patients Source: Eur Respir J 2005; 26: Suppl. 49, 59s Year: 2005 Endogenous and exogenous metabolites in exhaled breath condensate in asthma Source: Annual Congress 2012 - Exhaled biomarkers in airway diseases Year: 2012 Increased exhaled breath condensate cysteinyl leukotriene concentration in exercise-induced bronchoconstriction Source: Annual Congress 2011 - Clinical application of exhaled biomarkers Year: 2011 Exhaled breath condensate: 8-isoprostane and eicosanoids Source: Eur Respir Monogr 2010; 49: 196-206 Year: 2010 Adenosine in exhaled breath condensate in healthy volunteers and in patients with asthma Source: Eur Respir J 2002; 20: 1393-1398 Year: 2002 Noninvasive assessment of airway inflammation in asthma Source: ISSN=1025-448x, ISBN=1-904097-26-x, page=164 Year: 2003 Levels of 8-isoprostane and LTB4 in exhaled breath condensate (EBC) in seasonal allergic rhinitis. Effect of therapy and allergen exposure Source: Eur Respir J 2004; 24: Suppl. 48, 678s Year: 2004 Concentrations of nitric oxide metabolites in the exhaled breath condensate in children with different bronchial asthma control Source: Annual Congress 2012 - Exhaled biomarkers in airway diseases Year: 2012 Profile of prostanoids in exhaled breath condensate in childhood asthma Source: Eur Respir J 2003; 22: Suppl. 45, 400s Year: 2003 Cysteinyl leukotrienes in exhaled breath condensate are reduced after mite avoidance in allergic asthmatic children Source: Eur Respir J 2002; 20: Suppl. 38, 412s Year: 2002 Saliva is one likely source of leukotriene B4 in exhaled breath condensate Source: Eur Respir J 2006; 28: 1229-1235 Year: 2006 Prostaglandin E2 in the expired breath condensate of asthmatic patients Source: Eur Respir J 2001; 18: Suppl. 33, 165s Year: 2001 Effects of inhaled steroid therapy on exhaled breath condensate and blood biomarkers in newly diagnosed smoker asthmatics Source: International Congress 2014 – Rationale behind respiratory drug development Year: 2014 Additive contribution of exhaled nitric oxide and sputum eosinophils to airway responsiveness Source: International Congress 2015 – Exhaled biomarkers in monitoring airways disease Year: 2015 The effect of antioxidant therapy on nitric oxide metabolites in exhaled breath condensate in patients with pollen allergy and bronchial asthma Source: Annual Congress 2007 - Airway regulation, provocation and monitoring - III Year: 2007 Exhaled bronchial NO and cysteinyl-leukotrienes in breath condensate in atopic children Source: Eur Respir J 2002; 20: Suppl. 38, 412s Year: 2002